Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Heng-Kwei Chang"'
Autor:
Be-Sheng Kuo, Chao-Hung Li, Jiun-Bo Chen, Yu-Yu Shiung, Chia-Yu Chu, Chih-Hung Lee, Yaw-Jen Liu, Je-Hung Kuo, Cindy Hsu, Hsiao-Wen Su, Ywan-Feng Li, Annie Lai, Yueh-Feng Ho, Yi-Ning Cheng, Hong-Xuan Huang, Meng-Chung Lung, Ming-Syue Wu, Fu-Hung Yang, Chen-Han Lin, William Tseng, Jasper Yang, Chia-Yin Lin, Pei-Hua Tsai, Heng-Kwei Chang, Yi-Jen Wang, Techeng Chen, Shugene Lynn, Mei-June Liao, Chang Yi Wang
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 15 (2023)
Over the last 2 decades, omalizumab is the only anti-IgE antibody that has been approved for asthma and chronic spontaneous urticaria (CSU). Ligelizumab, a higher-affinity anti-IgE mAb and the only rival viable candidate in late-stage clinical trials
Externí odkaz:
https://doaj.org/article/fac742fb52aa43f781d834d2b06813e8
Autor:
Heng-Kwei Chang, 張恆魁
102
Retinoic acid (RA), an active metabolite converted from vitamin A, plays an active role in immune function, such as defending against infections and immune regulation. Although RA affects various types of immune cells, including antigen-pres
Retinoic acid (RA), an active metabolite converted from vitamin A, plays an active role in immune function, such as defending against infections and immune regulation. Although RA affects various types of immune cells, including antigen-pres
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/s5j2mh
Autor:
Be-Sheng Kuo, Chao-Hung Li, Jiun-Bo Chen, Yu-Yu Shiung, Chia-Yu Chu, Chih-Hung Lee, Yaw-Jen Liu, Je-Hung Kuo, Cindy Hsu, Hsiao-Wen Su, Ywan-Feng Li, Annie Lai, Yueh-Feng Ho, Yi-Ning Cheng, Hong-Xuan Huang, Meng-Chung Lung, Ming-Syue Wu, Fu-Hong Yang, Chen-Han Lin, William Tseng, Jasper Yang, Chia-Yin Lin, Pei-Hua Tsai, Heng-Kwei Chang, Yi-Jen Wang, Techeng Chen, Shugene Lynn, Mei-June Liao, Chang Yi Wang
Publikováno v:
Journal of Clinical Investigation. 132
Over the last 2 decades, omalizumab is the only anti-IgE antibody that has been approved for asthma and chronic spontaneous urticaria (CSU). Ligelizumab, a higher-affinity anti-IgE mAb and the only rival viable candidate in late-stage clinical trials
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecdf7e344f33a55e4f94606af4a3de45
https://doi.org/10.1172/jci157765
https://doi.org/10.1172/jci157765
Autor:
Heng-Kwei Chang, Wu-Shiun Hou
Retinoic acid (RA), an active metabolite converted from vitamin A, plays an active role in immune function, such as defending against infections and immune regulation. Although RA affects various types of immune cells, including antigen-presenting ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ecb85ed57a4eacb08a808d7d370cdfd
https://europepmc.org/articles/PMC4350144/
https://europepmc.org/articles/PMC4350144/